Steroid therapy in an alpha-dystroglycanopathy due to GMPPB gene mutations: A case report

[1]  T. Toda,et al.  Mechanistic aspects of the formation of α-dystroglycan and therapeutic research for the treatment of α-dystroglycanopathy: A review. , 2016, Molecular aspects of medicine.

[2]  Yubo Sun,et al.  Glucocorticoid Steroid and Alendronate Treatment Alleviates Dystrophic Phenotype with Enhanced Functional Glycosylation of α-Dystroglycan in Mouse Model of Limb-Girdle Muscular Dystrophy with FKRPP448L Mutation. , 2016, The American journal of pathology.

[3]  K. Bushby,et al.  This Work Is Licensed under a Creative Commons Attribution 4.0 International License Mutations in Gmppb Cause Congenital Myasthenic Syndrome and Bridge Myasthenic Disorders with Dystroglycanopathies , 2022 .

[4]  D. MacArthur,et al.  Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan. , 2013, American journal of human genetics.

[5]  Yen-Mou Lu,et al.  Strength and Functional Measurement for Patients with Muscular Dystrophy , 2012 .

[6]  R. Finkel,et al.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management , 2010, The Lancet Neurology.

[7]  N. Darín,et al.  Inflammation and response to steroid treatment in limb-girdle muscular dystrophy 2I. , 2007, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[8]  Susan C. Brown,et al.  Fukutin gene mutations in steroid‐responsive limb girdle muscular dystrophy , 2006, Annals of neurology.

[9]  Jacques Fermanian,et al.  A motor function measure scale for neuromuscular diseases. Construction and validation study , 2005, Neuromuscular Disorders.

[10]  A. Engel,et al.  Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies , 1998, Neurology.

[11]  K. Davies,et al.  The effect of glucocorticoids on the accumulation of utrophin by cultured normal and dystrophic human skeletal muscle satellite cells , 1995, Neuromuscular Disorders.

[12]  R. Sklar,et al.  Methylprednisolone increases dystrophin levels by inhibiting myotube death during myogenesis of normal human muscle in vitro , 1991, Journal of the Neurological Sciences.

[13]  R. Griggs,et al.  Effect of prednisone on protein metabolism in Duchenne dystrophy. , 1995, The American journal of physiology.